Pages that link to "Q40315135"

The following pages link to Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer (Q40315135):

Displaying 24 items.

• Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs (Q21090122) (← links)
• Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting (Q33324374) (← links)
• Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer (Q33511900) (← links)
• Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics (Q33745230) (← links)
• BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse (Q33851427) (← links)
• Buruli ulcer (Q34229628) (← links)
• Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease. (Q35746584) (← links)
• Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model (Q35857386) (← links)
• Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer. (Q35915755) (← links)
• Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice (Q35919532) (← links)
• Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study (Q36863072) (← links)
• Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation (Q36733497) (← links)
• Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans (Q37349850) (← links)
• Buruli ulcer disease: prospects for a vaccine (Q37387041) (← links)
• FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer. (Q39215467) (← links)
• Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice (Q39580405) (← links)
• A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice (Q42799618) (← links)
• Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection (Q43855252) (← links)
• DNA vaccines against mycobacterial diseases (Q57203115) (← links)
• Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans (Q57203196) (← links)
• IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection (Q58880192) (← links)
• The immunology of other mycobacteria: M. ulcerans, M. leprae (Q89886649) (← links)
• In Vivo Imaging of Bioluminescent Mycobacterium ulcerans: A Tool to Refine the Murine Buruli Ulcer Tail Model (Q90603894) (← links)
• High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice (Q98726963) (← links)